The application of proteomics to diabetes

Diabetes and Vascular Disease Research

Volumn 2, Issue 2, 2005, Pages 54-60

  Scott, Eleanor M ^a   Carter, Angela M ^a   Findlay, John B C ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Leeds University ^*

Author keywords

Diabetes; ESI; MALDI; Mass spectrometry; Proteomics; SELDI; Two dimensional gel electrophoresis (2DE)

Indexed keywords

DIABETES MELLITUS; ELECTROSPRAY MASS SPECTROMETRY; EVIDENCE BASED MEDICINE; FUNCTIONAL PROTEOMICS; GEL ELECTROPHORESIS; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL RESEARCH; MOLECULAR MECHANICS; PROCESS DESIGN; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SCREENING TEST; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EID: 20444501064     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2005.009     Document Type: Review

References (46)

1. Kelly MA, Rayner ML, Mijovic CH, Barnett AH. Molecular aspects of type 1 diabetes. Mol Pathol 2003;56:1-10.
2. White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002;283:E413-E422.
3. Pickup J, Williams G. Textbook of Diabetes. Oxford: Blackwell Science, 1997.
4. Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab 2003;29:6S9-18.
5. Hsueh WA, Law R. The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease. Am J Cardiol 2003;92:3J-9J.
6. Goldfine AB, Kahn CR. Adiponectin: linking the fat cell to insulin sensitivity. Lancet 2003;362:1431-2.
7. Stern MP. Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents? Ann Intern Med 1996;124:110-16.
8. Banks RE, Dunn MJ, Hochstrasser DF et al. Proteomics: new perspectives, new biomedical opportunities. Lancet 2000;356:1749-56.
9. Wang H, Hanash S. Multi-dimensional liquid phase based separations in proteomics. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 787:11-18.
10. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003;422:198-207.
11. Zhu H, Bilgin M, Snyder M. Proteomics. Annu Rev Biochem 2003;72:783-812.
12. Tyers M, Mann M. From genomics to proteomics. Nature 2003;422:193-7.
13. Tang N, Tornatore P, Weinberger SR. Current developments in SELDI affinity technology. Mass Spectrom Rev 2004;23:34-44.
14. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975;250:4007-21.
15. Sivakumar A. 2D gels and bioinformatics - an eye to the future. In Silico Biol 2002;2:507-10.
16. Henzel WJ, Watanabe C, Stults JT. Protein identification: the origins of peptide mass fingerprinting. J Am Soc Mass Spectrom 2003;14:931-42.
17. Mann M, Wilm M. Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal Chem 1994;66:4390-9.
18. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551-67.
19. Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 2004;20:777-85.
20. Hanash S. Building a foundation for the human proteome: the role of the Human Proteome Organization. J Proteome Res 2004;3:197-9.
21. Nerup J, Mandrup-Poulsen T, Helqvist S et al. On the pathogenesis of IDDM. Diabetologia 1994;37(suppl 2):S82-S89.
22. Nerup J, Mandrup-Poulsen T, Molvig J, Helqvist S, Wogensen L, Egeberg J. Mechanisms of pancreatic beta-cell destruction in type I diabetes. Diabetes Care 1988;11(suppl 1):16-23.
23. Chiasson JL, Rabasa-Lhoret R. Prevention of type 2 diabetes: insulin resistance and beta-cell function. Diabetes 2004;53(suppl 3):S34-S38.
24. Hu L, Evers S, Lu ZH, Shen Y, Chen J. Two-dimensional protein data-base of human pancreas. Electrophoresis 2004;25:512-18.
25. Sanchez JC, Chiappe D, Converset V et al. The mouse SWISS-2D PAGE database: a tool for proteomics study of diabetes and obesity. Proteomics 2001;1:136-63.
26. Sparre T, Christensen UB, Gotfredsen CF et al. Changes in expression of IL-1 beta influenced proteins in transplanted islets during development of diabetes in diabetes-prone BB rats. Diabetologia 2004;47:892-908.
27. Sanchez JC, Converset V, Nolan A et al. Effect of rosiglitazone on the differential expression of diabetes-associated proteins in pancreatic islets of C57BI/6 lep/lep mice. Mol Cell Proteomics 2002;1:509-16.
28. Collier JJ, Scott DK. Sweet changes: glucose homeostasis can be altered by manipulating genes controlling hepatic glucose metabolism. Mol Endocrinol 2004;18:1051-63.
29. Edvardsson U, Alexandersson M, Brockenhuus VL et al. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643. Electrophoresis 1999;20:935-42.
30. Edvardsson U, von Lowenhielm HB, Panfilov O, Nystrom AC, Nilsson F, Dahllof B. Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators. Proteomics 2003;3:468-78.
31. Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 1999; 277:E1-E10.
32. Hojlund K, Wrzesinski K, Larsen PM et al. Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem 2003;278:10436-42.
33. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001;280:E827-E847.
34. Considine RV, Nyce MR, Morales LM et al. Paracrine stimulation of preadipocyte-enriched cell cultures by mature adipocytes. Am J Physiol 1996;270:E895-E899.
35. Gabriely I, Ma XH, Yang XM et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 2002;51:2951-8.
36. Xu A, Choi KL, Wang Y et al. Identification of novel putative membrane proteins selectively expressed during adipose conversion of 3T3-L1 cells. Biochem Biophys Res Commun 2002;293:1161-7.
37. Wilson-Fritch L, Burkart A, Bell C et al. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol 2003;23:1085-94.
38. Choi KL, Wang Y, Tse CA, Lam KS, Cooper GJ, Xu A. Proteomic analysis of adipocyte differentiation: Evidence that alpha2 macroglobulin is involved in the adipose conversion of 3T3 L1 preadipocytes. Proteomics 2004;4:1840-8.
39. Kratchmarova I, Kalume DE, Blagoev B et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002;1:213-22.
40. Shen X, Zheng S, Thongboonkerd V et al. Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am J Physiol Endocrinol Metab 2004;287:E896-E905.
41. Marshall SM. Recent advances in diabetic nephropathy. Clin Med 2004;4:277-82.
42. Thongboonkerd V, Barati MT, McLeish KR et al. Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis. J Am Soc Nephrol 2004;15:650-62.
43. Mischak H, Kaiser T, Walden M et al. Proteomic analysis for the assessment of diabetic renal damage in humans. Clin Sci (Lond) 2004;107:485-95.
44. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845-67.
45. Omenn GS. The Human Proteome Organization Plasma Proteome Project pilot phase: reference specimens, technology platform comparisons, and standardized data submissions and analyses. Proteomics 2004;4:1235-40.
46. Zhang R, Barker L, Pinchev D et al. Mining biomarkers in human sera using proteomic tools. Proteomics 2004;4:244-56.